Laser Portfolio

Important Safety Information

The Lumenis Pulse 120H Holmium Laser System with fibers and accessories are intended for use in surgical procedures involving open, laparoscopic and endoscopic ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including, but not limited to, urology and urinary lithotripsy.  It is contraindicated for carcinoma of the prostate and patients who are unable to receive endoscopic treatments or are intolerant to prolonged anesthesia, as well as for resection or excision of large vascularized organs.  Holmium lasers are intended solely for use by physicians trained in the use of the Ho:YAG (2.1 μm) wavelength.  Incorrect treatment settings can cause serious tissue damage.  The laser should be used only on tissues that are fully observable.  Potential adverse events include, but are not limited to, chills, fever, edema, hemorrhage, inflammation, tissue necrosis, infection or scarring.  Review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, and potential adverse events.

The MOSES Raydar Holmium Surgical Laser with fibers and accessories is intended for use in surgical procedures involving endoscopic ablation, vaporization, excision, incision, and coagulation of soft tissue and lithotripsy of calculi in the medical specialty of urology. It is contraindicated for carcinoma of the prostate and patients who are unable to receive endoscopic treatments or are intolerant to anesthesia. Holmium lasers are intended solely for use by physicians trained in the use of the Ho:YAG (2.1 μm) wavelength. Incorrect treatment settings can cause serious tissue damage. The laser should be used only on tissues that are fully observable. Potential adverse events include, but are not limited to fever, edema, hemorrhage, inflammation, adhesions, burns, infection, pain/discomfort, or retrograde ejaculation. Review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, and potential adverse events.

References:

1. Ibrahim A, Elhilali MM, Fahmy N, et al. Double-blinded prospective randomized clinical trial comparing regular and Moses modes of holmium laser lithotripsy. J Endourol. 2020 May;34(5):624-8.
2. Elhilali MM, Badaan S, Ibrahim A, et al. Use of the Moses technology to improve holmium laser lithotripsy outcomes: A preclinical study. J Endourol. 2017 Jun;31(6):598-604.
3. Leotsakos I, Katafigiotis I, Lorber A, et al. Initial experience in combined ultra-mini percutaneous nephrolithotomy with the use of 120-W laser and the anti-retropulsion “Moses effect”: the future of percutaneous nephrolithotomy? Lasers Med Sci. 2020 Dec;35(9):1961-66.

Disclaimers
When discussing the stone management portfolio, claims apply to one or more products that could meet the needs of the patient and/or provider. Refer to associated references for applicable products.
The testing was performed by or on behalf of BSC. Data on file.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products are shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Rx only.
This material is not intended for use in France. For product availability in your country please check with your local Boston Scientific representative. Kidney stone pictures are for illustrative purposes only. Source: Getty Images and Adobe Stock. 
All other images are the property of Boston Scientific.
All trademarks are the property of their respective owners.
CE 0483 MOSES Raydar™